Venkateshwaran Krishnaswami | Drug Delivery | Excellence in Research

Dr. Venkateshwaran Krishnaswami | Drug Delivery | Excellence in Research 

Sa Raja Pharmacy College | India

AUTHOR PROFILE

EARLY ACADEMIC PURSUITS

Dr. Venkateshwaran Krishnaswami embarked on his academic journey with a Bachelor's degree in Pharmacy from Dr. M. G. R Medical University, Chennai, Tamil Nadu, India, in April 2006, securing 73.3%. He continued his education at the same university, earning a Master's degree in Pharmaceutical Biotechnology in February 2008 with an impressive 81.3%. His academic excellence was further demonstrated when he obtained his PhD from Anna University, BIT Campus, Tiruchirappalli, Tamil Nadu, India, in December 2015, graduating with an A Grade. These achievements laid a solid foundation for his subsequent career in pharmaceutics and drug delivery systems.

PROFESSIONAL ENDEAVORS

Dr. Krishnaswami has amassed over 14 years and 7 months of experience in teaching and research. He currently serves as Vice Principal and Professor at S.A. Raja Pharmacy College, Vadakangulam. His prior roles include serving as an Incubation Scientist and Young Scientist at Anna University BIT Campus, Tiruchirappalli, and as a Professor at Nova College of Pharmaceutical Education and Research, Telangana. His teaching portfolio spans B Pharm, Pharm D, and M Pharm courses, focusing on various aspects of pharmaceutics. His involvement in academia extends to administrative duties, including organizing IAEC meetings, NBA accreditations, and university examination-related activities.

CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Krishnaswami’s research is centered on Drug Delivery systems, particularly nanomicellar pulmonary delivery for chronic obstructive pulmonary diseases and nanoparticulate systems for ocular therapy. His PhD research focused on efficient drug delivery to the posterior segment of the eye for treating age-related macular degeneration. He has also worked on developing technologies such as oral films loaded with antihypertensive drugs, calcium phosphate nanoparticles for dental implants, methotrexate cubosomes for rheumatoid arthritis, and wet wipes technology. His efforts have been recognized with several awards, including the Young Scientist Award from the Department of Health Research, New Delhi, and the Best Researcher Award from VD GOOD Technology Factory, Trivandrum.

IMPACT AND INFLUENCE

Dr. Krishnaswami has significantly impacted the field of Drug Delivery through his innovative research and development of new delivery systems. His work on nanomicellar pulmonary delivery and ocular nanoparticulate systems has provided new insights and solutions for treating chronic diseases. His contributions have been widely recognized, as evidenced by his h-index of 17 and various honors, such as the Young Scientist Award from Crescent Institute of Technology and the Academic Excellence Award from Dr. M. G. R University. His role in establishing and managing the EDII-Anna Business Incubation Research Foundation highlights his commitment to fostering innovation and entrepreneurship in the pharmaceutical sector.

ACADEMIC CITATIONS

Dr. Krishnaswami's research has garnered significant academic recognition, reflected in his numerous publications and citations. He has published several papers related to HPLC method development and validation, contributing to the advancement of analytical techniques in pharmaceutics. His publications, such as those in Pharmaceutica Analytica Acta and articles in Spinco Biotech's "Cutting Edge" magazine, have provided valuable insights into the characterization of nanomedicines and novel drug delivery systems. His research has not only advanced the field but also served as a crucial reference point for fellow researchers and practitioners.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Krishnaswami's legacy in the field of Drug Delivery is marked by his innovative approaches to solving complex pharmaceutical challenges. His work has laid the groundwork for future research in nanoparticulate drug delivery systems and their applications in treating various diseases. Looking ahead, he aims to continue his pioneering research, focusing on developing advanced drug delivery systems that enhance therapeutic efficacy and patient outcomes. His ongoing contributions will undoubtedly influence the future direction of pharmaceutical sciences and provide new avenues for effective disease treatment.

DRUG DELIVERY

Dr. Venkateshwaran Krishnaswami's career has been profoundly influenced by his dedication to Drug Delivery research. His innovative work in developing nanomicellar pulmonary delivery systems and nanoparticulate drug delivery for ocular diseases has pushed the boundaries of pharmaceutical sciences. His research has addressed critical challenges in drug delivery, such as enhancing bioavailability and targeting specific disease sites. By focusing on novel delivery technologies, Dr. Krishnaswami continues to contribute significantly to the field, ensuring that his work remains at the forefront of pharmaceutical innovation.

NOTABLE PUBLICATION

 

Sara Mahshid | Biomedical Engineering | Best Researcher Award 

Prof. Sara Mahshid | Biomedical Engineering | Best Researcher Award 

McGill University | Canada

Author Profile

Early Academic Pursuits:

Dr. Sara Mahshid embarked on her academic journey with a fervent passion for exploring the intersections of nanotechnology and biomedical engineering. Her early academic pursuits were characterized by a dedicated focus on understanding the fundamental principles governing nanostructures and their applications in biosensing and biomedicine. Through rigorous research and academic endeavors, she laid the groundwork for her future contributions to the field.

Professional Endeavors:

Throughout her career, Dr. Mahshid has been actively involved in various professional endeavors aimed at advancing the field of biomedical engineering. As an Assistant Professor at McGill University, she has spearheaded groundbreaking research projects, collaborated with leading experts in the field, and published prolifically in esteemed journals. Her commitment to excellence and innovation has been evident in her diverse portfolio of work.

Contributions and Research Focus:

Dr. Mahshid's research focus spans a wide array of topics within biomedical engineering, with a particular emphasis on nanotechnology-enabled biosensors, microfluidic devices, and electrochemical sensing platforms. Her contributions have significantly advanced our understanding of these technologies, paving the way for their application in disease diagnosis, drug delivery, and personalized medicine. Through her innovative research, she has addressed critical challenges in healthcare and biotechnology, driving meaningful impact in the field.

Citations

  • Citations    2918
  • h-index      27
  • i10-index  43

Impact and Influence:

Dr. Mahshid's work has had a profound impact on the biomedical engineering community, inspiring researchers and practitioners alike to explore new frontiers in nanotechnology and biosensing. Her groundbreaking discoveries have not only expanded the boundaries of scientific knowledge but have also translated into tangible solutions with real-world applications. By bridging the gap between academia and industry, she has catalyzed innovation and contributed to the advancement of healthcare technologies.

Academic Cites:

Dr. Mahshid's research has garnered widespread recognition and acclaim within the academic community, as evidenced by the numerous citations her work has received in peer-reviewed journals and conference proceedings. Her innovative contributions have been cited extensively by fellow researchers, highlighting the significance and relevance of her findings in the field of biomedical engineering.

Legacy and Future Contributions:

As a trailblazer in the field of biomedical engineering, Dr. Sara Mahshid has established a lasting legacy through her pioneering research, mentorship of future scientists, and advocacy for interdisciplinary collaboration. Her work has laid the foundation for continued innovation and discovery in nanotechnology-enabled biosensing, setting the stage for transformative advancements in healthcare and biomedicine. Moving forward, she remains committed to pushing the boundaries of scientific knowledge and driving positive change through her research endeavors.

Notable Publication